Apotea AB

Apotea AB

APOTEA.ST
Apotea ABSE flagStockholm Stock Exchange
77.50
SEK
+1.00
- -
8.07BMarket Cap
Apotea AB
APOTEA.ST
(Stockholm Stock Exchange)

Recent

price

77.50

P/E

ratio

- -

div

yld

- -

ROIC.AI

2021
2022
2023
2024
2025
TTM
FRC
44
46.92
52.37
63.78
69.22
66.87
Revenue per Share
1.01
0.19
0.84
2.1
2.2
2.4
Basic EPS, GAAP
1.41
-1.06
0.91
0.41
1.13
1.51
Free Cash Flow per Basic Share
0.27
0.27
- -
- -
- -
- -
Dividend per Share
3.13
3
3.74
5.88
8.01
7.19
Book Value per Share
3.21
2.82
3.54
5.71
7.83
7.05
Tangible Book Value per Share
104
104
104
103
104
104
Basic Weighted Avg Shares
4,580
4,883
5,450
6,541
7,203
6,938
Sales/Revenue/Turnover
2.93
1
2.07
4.02
4.22
4.52
Operating Margin (%)
50
70
113
130
162
137
Depreciation Expense
105
20
87
215
229
249
Net Income, GAAP
19.86
40.97
24.29
19.91
21.91
19.73
Effective Tax Rate (%)
2.29
0.41
1.6
3.29
3.17
3.59
Profit Margin (%)
152
5
25
141
247
171
Working Capital
124
179
150
111
249
265
LT Debt
341
355
425
636
860
778
Total Equity
- -
4.86
12.38
26.43
22.06
111.99
Return on Invested Capital (%)
- -
4.15
14.16
28.89
23.51
119.02
Return on Capital (%)
- -
6.23
24.81
43.35
31.86
180.55
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Dec'24
Mar'25
Jun'25
ST Debt
131
152
67
LT Borrowings
- -
- -
- -
LT Finance Leases
111
240
265
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
104
104
104
Market Capitalization
8,720
7,562
9,151

Working Capital

FRC

in mil. unless spec.
Dec'24
Mar'25
Jun'25
Total Current Assets
1,021
1,067
1,103
Cash, Cash Equivalents & STI
27
21
69
Accounts Receivable, Net
359
355
369
Inventories
562
613
588
Total Current Liabilities
881
976
932
Payables & Accruals
- -
- -
- -
ST Debt
131
152
67
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
35.2%
Free Cash Flow
- -
- -
177.59%
Net Income, GAAP
- -
- -
6.42%
Sales/Revenue/Turnover
- -
- -
10.12%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,522
1,661
1,625
1,733
6,541
2025
1,754
1,826
1,854
- -
7,203
2026
1,937
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.47
0.58
- -
0.48
2.1
2025
0.69
0.69
0.15
- -
2.2
2026
0.76
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
Apotea AB, online pharmacy and e-commerce retailer, operates Sweden’s largest pure online pharmacy platform delivering a broad assortment of health, wellness, and pharmaceutical products directly to consumers through an integrated digital storefront and logistics network. Main products and services - Online pharmacy offerings: prescription medications (where legally permitted), over-the-counter medicines, and patient-specific pharmaceutical services; pharmacy-grade processes and compliance safeguards; pharmacist consultations and support through digital channels - Health and wellness products: vitamins, dietary supplements, nutraceuticals, and functional foods; allergy remedies; digestive health products; pain relief and cold/flu items; ophthalmic and dermatological care products - Personal care and beauty: skincare, haircare, makeup, sun protection, and grooming products; cosmetics and toiletries - Baby, parent, and family care: baby care essentials, pediatric health items, maternity and parenting products - Home, health, and medical supplies: first-aid, wound care, personal protective equipment, home medical devices and assistive devices - Animal health and care: veterinary care items, pet medications, and wellness products - Dietary and lifestyle categories: weight management, sleep aids, smoking cessation and stress relief products Geographic operations and market presence - Primary market: Sweden, with an expanding footprint in neighboring Nordic regions; strong online distribution with nationwide delivery - Logistics and fulfillment: operates centralized fulfillment capabilities to support rapid delivery and refrigerated shipping options for temperature-sensitive medicines; continues to enhance delivery options, including free delivery thresholds and expanded refrigerated offerings - Regulatory and compliance framework: adheres to national pharmaceutical and consumer protection standards; maintains licensed pharmacy operations and pharmacist-led services where required Founding and corporate structure - Founded in 2011; headquarters in Stockholm, Sweden - Listed on Nasdaq Stockholm in 2024 (ticker APOTEA); operates as a publicly traded company with a focus on scaling its digital pharmacy model Recent major changes and developments - Expansion into refrigerated pharmaceutical deliveries and broadened free-delivery options to improve customer convenience and product integrity - Soft launch of beauty and health product assortment in Norway under the Apotea brand, signaling geographic expansion beyond Sweden - Continued growth in revenue and profitability with ongoing investments in fulfillment capacity, logistics, and technology to support scale and customer experience - Strategic focus on product category expansion and enhanced service propositions to sustain accelerated growth while maintaining strong margins Industry and business segments - E-commerce retail in health, beauty, and wellness - Pharmacy services, including online prescribing support and pharmacist consultations - Direct-to-consumer distribution of pharmaceuticals, dietary supplements, personal care, and veterinary products Target markets and customers - Individual consumers seeking convenient access to medicines, health and wellness products, and personal care items - Parents and families requiring baby and maternity-related products - Pet owners seeking veterinary and pet-health products Subsidiaries and corporate relationships - Apotea AB operates as the parent company with subsidiary and affiliate structures supporting logistics, product sourcing, and market expansion within the Nordic region as part of its growth strategy Note: This description summarizes Apotea AB’s core products, services, recent strategic moves, and operational footprint based on the latest publicly available information. The company continues to evolve its product mix, delivery capabilities, and regional reach as part of its growth trajectory in the Nordic online pharmacy and e-commerce landscape.